cjc 1295 ipamorelin and mots c Metabolic Signaling Bundle CJC-1295 No DAC & Ipamorelin
Description
Oncogene 19 , 15091518 (2000)
W., Kwon, G
The role of mTOR in the adaptation and failure of -cells in type 2 diabetes
A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy
